Home Investors & Media The 2017 ASH Sapacitabine SEAMLESS Phase 3 Results Investors & Media << Back Corporate Presentations & Events The 2017 ASH Sapacitabine SEAMLESS Phase 3 Results 12/12/17 12:00 AM EST Supporting Materials View Presentation 1.4 MB Investors & Media Investor Relations Corporate Governance Board of Directors Committee Composition Management Team Common Stock Information News SEC Filings Analysts Corporate Presentations & Events Corporate Factsheet Annual Reports Archive Request Investor Pack Alerting Service Investor Tools Email Alerts Download Library RSS News Feeds Print Page Share This Share this on: Delicious Digg Facebook LinkedIn Twitter
Corporate Presentations & Events The 2017 ASH Sapacitabine SEAMLESS Phase 3 Results 12/12/17 12:00 AM EST Supporting Materials View Presentation 1.4 MB
Investors & Media Investor Relations Corporate Governance Board of Directors Committee Composition Management Team Common Stock Information News SEC Filings Analysts Corporate Presentations & Events Corporate Factsheet Annual Reports Archive Request Investor Pack Alerting Service Investor Tools Email Alerts Download Library RSS News Feeds Print Page Share This Share this on: Delicious Digg Facebook LinkedIn Twitter
Delicious
Digg
Facebook
LinkedIn
Twitter